The global encapsulated salicylic acid market is entering a high-growth phase, projected to expand from USD 12.54 million in 2026 to USD 35.61 million by 2036, registering a CAGR of 11.0%. Growth is being driven by the increasing shift toward advanced dermocosmetic formulations where controlled-release actives are essential for balancing efficacy with skin tolerance.
Encapsulation technologies...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Greek